Find uplifting stories about heroes, innovations, and solutions
19086 results for "** vaccination success"
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
India's Assam state has achieved 87.7% vaccination coverage, showing remarkable progress even as measles outbreaks return globally. The success comes despite flooding, migration, and access challenges that still leave some children without vaccines.
After decades without a vaccine option, Pfizer's new Lyme disease vaccine showed over 70% effectiveness in preventing infection among 9,400 participants. The breakthrough could protect the 476,000 Americans infected annually from a disease that often leads to chronic arthritis and heart problems.
South Africa's aggressive vaccination campaign against Foot-and-Mouth Disease has protected over 2 million farm animals in just six weeks, with zero new infections reported in vaccinated herds. The early success offers hope to farmers across all nine provinces battling the livestock threat.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
A new vaccine prevented pancreatic cancer from developing in 20 high-risk patients, with 90% showing lasting immune responses. For the first time, researchers have found a way to intercept one of the deadliest cancers before it starts.
Rajshahi City Corporation vaccinated 104% of its target goal for measles and rubella, protecting over 57,000 children in just three weeks. The success story shows what's possible when communities rally around children's health.
Kenya nearly doubled its HPV vaccination rate in 2026, protecting hundreds of thousands of adolescent girls from cervical cancer. The success story shows what's possible when governments invest in prevention programs that save lives.
Scientists at the University of Guelph have successfully tested the world's first vaccine against Campylobacter jejuni, a bacterial infection that causes millions of cases of severe diarrhea worldwide each year. The Phase 1 trial showed the vaccine is safe and triggers strong immune responses at even low doses.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
India is launching a major push to vaccinate 130 million older adults against preventable diseases, addressing a critical gap where less than 5% are currently protected. The initiative aims to replicate the success of childhood vaccination programs that have saved millions of lives.
A groundbreaking vaccine trial just achieved 89% effectiveness against shigellosis, a disease that kills over a million people yearly, nearly half of them children under five. After a century of failed attempts, researchers finally have real hope for preventing a killer that's been overlooked for far too long.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
For the first time in history, cervical cancer deaths fell to zero among women aged 20-24 in England. The breakthrough proves we can actually prevent cancer through vaccination.
After 14 years of research, San Diego scientists developed an HIV vaccine that successfully triggered virus-fighting antibodies in nearly half of the primates tested. The breakthrough could lead to the first effective HIV vaccine for humans within years.
After 997 cases, South Carolina officially ended its worst measles outbreak in over 35 years thanks to massive community vaccination efforts. The real win: 82,000 people got vaccinated, with some areas seeing vaccination rates jump 94%.
A personalized mRNA cancer vaccine combined with existing treatment successfully slowed melanoma's return in a groundbreaking late-stage trial. This first-of-its-kind success could open new doors for cancer patients worldwide.
A personalized mRNA cancer vaccine developed by Moderna and Merck has shown remarkable success in preventing melanoma from returning. The breakthrough sent Moderna's stock soaring 90% and offers new hope for treating cancer beyond COVID vaccines.
Showing 20 of 19086